The D.C. biotech also filed a shelf registration statement for $200 million, opening the door for it to raise that money over ...

Software stocks have been getting absolutely killed lately due to fears that wider AI adoption could threaten their ...

The FDA has set a Feb. 21 target decision on the Bysanti NDA. ・Vanda submitted the NDA in March 2025 for Bysanti to treat acute bipolar I disorder and schizophrenia. ・In May, the FDA said the ...

Our fourth quarter and full year 2025 results were released this afternoon and are available on the SEC’s EDGAR system and on our website, Joining me on today’s call is Mihael H. Polymeropoulos, our ...

Vanda Pharmaceuticals (NASDAQ:VNDA) highlighted strong growth for its lead product Fanapt and detailed several late-stage ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter ...

Detailed price information for Amn Healthcare Services Inc (AMN-N) from The Globe and Mail including charting and trades.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-2.39 EPS, expectations were ...

As of Friday, February 06, Vanda Pharmaceuticals Inc.’s VNDA share price has surged by 6.36%, which has investors questioning if this is right time to sell.

Brayer covers the Healthcare sector, focusing on stocks such as Vanda, CytomX Therapeutics, and Insmed. According to TipRanks, Brayer has an average return of 6.7% and a 46.15% success rate on ...

Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today?. <li />Certain debt securities or warrants could be converted ...

Brown, a scholar of international organized crime, discusses the specter of violent conflict between Mexican cartels and the current U.S. administration.